To assess safety in elderly BRAF V600 mutation-positive advanced melanoma patients treated with dabrafenib and trametinib and correlation with non-elderly patients
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Dabrafenib (Primary) ; Trametinib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress